Jan Sadones

miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells

Gang Chen, Ijeoma Adaku Umelo, Shasha Lv et al. · PLoS ONE · 2013 · 266 citations · Full text

Immunology, Cell Death, Cancer Biology +20

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

Bart Neyns, Jan Sadones, E. Joosens et al. · Annals of Oncology · 2009 · 239 citations · Full text

Medicine, Metronomic Therapy, Recurrent High-grade Glioma +8

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

Bart Neyns, Jan Sadones, C. Chaskis et al. · Journal of Neuro-Oncology · 2010 · 138 citations

Tumoral Pathology, Sunitinib Malate, Glioma +12

Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab

Shasha Lv, Erik Teugels, Jan Sadones et al. · International Journal of Oncology · 2012 · 64 citations · Full text

Gene Amplification, Pathology, High-grade Gliomas +17

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma

Jan Sadones, Alex Michotte, Pieter In 'T Veld et al. · European Journal of Cancer · 2008 · 54 citations

Neuro-oncology, Survival Benefit, Tumoral Pathology +10